Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Acamprosate Fragile X Syndrome Youth Study
Clinical Trial Protocol ID
12091405

Clinical Trial Investigator Name
Elizabeth Berry-Kravis

Clinical Trial Title

Study of acamprosate in youth with fragile X syndrome versus placebo



Clinical Trial Protocol Description

The purpose of this study is to learn more about the effectiveness of acamprosate versus placebo as a drug treatment for interfering symptoms associated with fragile X syndrome, such as irritability, hyperactivity and social impairment. This study will also help determine the amount of medicine that will be used in future treatment for children with FXS. Nationwide, 48 patients will be recruited for this study. At Rush University Medical Center, we expect to recruit approximately 24 patients. The treatment will be assigned randomly.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this study if you:

  • Are between the ages of 5-17 with a diagnosis of fragile X syndrome
  • Are able to swallow a large-capsule medication

You will be excluded from this study if you:

  • Are taking more than two psychotropic drugs
  • Have an unstable seizure disorder or a recent change in anti-convulsant drug dosing

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.





Contact Name Jamie Chin
Contact Phone (312) 942-0025
Promotional Information

Clinical Trials Home
Pediatric Neurology Trials
Acamprosate Fragile X Syndrome Youth Study

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois